Elsevier and International Society of Geriatric Oncology Launch Journal of Geriatric Oncology

New Journal Will Publish Research in the Developing Area of Geriatric Oncology

OXFORD, England, July 6, 2010 - Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, and the International Society of
Geriatric Oncology (SIOG) announced today the launch of the Journal of
Geriatric Oncology (www.geriatriconcology.net). The journal is focused
on advancing research in the pathogenesis, biology, treatment, and
survivorship issues of older adults with cancer. It covers all aspects of
geriatric oncology, from basic scientific research through to clinical
research, as well as research that is relevant to education and policy
development.

"Older adults represent the majority of individuals with cancer, and the
number of older individuals with cancer is growing as our society ages and
life expectancy increases. Despite such a compelling need for geriatric
oncology research, it has been challenging to disseminate this research into
mainstream geriatric or oncology journals," said Dr Arti Hurria,
Editor-in-Chief of the Journal of Geriatric Oncology.

Matti Aapro, Executive Director of SIOG and Founding Editor of the
Journal of Geriatric Oncology noted, "It is imperative that chronologic age
alone does not prevent senior adult patients from receiving treatment and
care for their cancer, which is in line with best practice. To achieve this
goal, there was clearly a need for a journal specialized in geriatric
oncology. Thus, Elsevier and the International Society for Geriatric Oncology
decided that it was time to launch the Journal of Geriatric Oncology, which
should become the leading source of updated information in this complex
area."

The Editorial Board is led by Editor-in-Chief, Arti Hurria, and Founding
Editor, Matti Aapro. Dr Hurria is a geriatrician and oncologist, focusing on
care of the older patient with cancer. She completed a geriatric fellowship
in the Harvard Geriatric Fellowship Program, followed by a
hematology-oncology fellowship at Memorial Sloan-Kettering Cancer Center
(MSKCC). Dr Hurria subsequently joined the faculty at MSKCC, and in 2006
joined the City of Hope as Director of the Cancer and Aging Research Program.
Dr. Hurria is a cadre member of the Cancer and Leukemia Group B, Cancer in
the Elderly Committee and is a recipient of the Paul Beeson Career
Development Award in Aging Research (K23 AG026749-01) and American Society of
Clinical Oncology-Association of Specialty Professors-Junior Development
Award in Geriatric Oncology.

Dr Aapro is Dean of the Multidisciplinary Oncology Institute at the
Clinique de Genolier in Genolier, Switzerland. In addition to his role as
Executive Director of SIOG, Dr. Aapro is also an active member of several
professional organizations. He is a Board member and past-President of the
Multinational Association for Supportive Care in Cancer (MASCC) and a member
and past-Chair of the Cancer in the Elderly Task Force of the European
Organization for Research and Treatment of Cancer (EORTC).

About the Journal of Geriatric Oncology

The Journal of Geriatric Oncology is an international, multidisciplinary
journal which is focused on advancing research in the pathogenesis, biology,
treatment, and survivorship issues of older adults with cancer. The journal
covers all aspects of geriatric oncology, from basic scientific research
through to clinical research, as well as research that is relevant to
education and policy development.

The Journal of Geriatric Oncology publishes original research articles,
review articles, clinical trials, treatment guidelines, education and
training articles, editorials, short communications, perspectives, meeting
reports and letters to the editor which comment on previously published work.
The Journal of Geriatric Oncology is the official journal of the
International Society of Geriatric Oncology (SIOG).

About the International Society of Geriatric Oncology (SIOG)

The International Society of Geriatric Oncology, or Societe
Internationale d'Oncologie Geriatrique in French (SIOG), was founded in 2000.
The major risk factor for cancer is age, and with the aging of the world
population, a major epidemiologic challenge is before us.

The goal of SIOG is to foster the development of health professionals in
the field of geriatric oncology, in order to optimize treatment of older
adults with cancer. It promotes efforts in training, research, policy and
care to support this mission. SIOG is a multidisciplinary society, including
physicians in the fields of oncology and geriatrics, and allied health
professionals. Its annual conference is the leading conference for experts in
the field to interact and share their results.

It has members in more than 40 countries around the world. SIOG honors a
prominent world expert in the field each year with the Calabresi Award, named
after its first president: Dr Paul Calabresi, past-President of the American
Society for Clinical Oncology (ASCO), whose vision contributed greatly to the
development of geriatric oncology.

For more information: www.siog.org

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com ), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com ) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes
more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Sarah Jenkins
    Publisher, Global Medical Research
    +44-1865-843243
    sl.jenkins@elsevier.com

Sarah Jenkins, Publisher, Global Medical Research, +44-1865-843243, sl.jenkins at elsevier.com